Stephens Upgrades Neogenomics (NEO) to Overweight

Stephens analyst Mason Carrico upgraded Neogenomics (NASDAQ: NEO) from Equal Weight to Overweight with a price target of $18.00 (from $16.00).

For an analyst ratings summary and ratings history on Neogenomics click here. For more ratings news on Neogenomics click here.

Shares of Neogenomics closed at $13.55 yesterday.

You May Also Be Interested In

• AngioDynamics (ANGO) PT Raised to $20 at Canaccord
• Antero Resources (AR) PT Lowered to $50 at UBS
• Ericsson (ERICB:SS) (ERIC) PT Lowered to SEK77 at BofA Securities